Biofrontera (BFRI) Other Accumulated Expenses (2024 - 2025)
Biofrontera (BFRI) recorded quarterly Other Accumulated Expenses of $320000.0 in Q4 2025, down 53.01% quarter-over-quarter from $681000.0 in Q3 2025, and down 47.8% on a YoY basis from $613000.0 in Q4 2024.
Biofrontera (BFRI) Other Accumulated Expenses (2024 - 2025) Analysis & Trends
Biofrontera's Other Accumulated Expenses history runs 2 years deep, the most recent figure standing at $320000.0 for Q4 2025.
- In Q4 2025, Other Accumulated Expenses fell 47.8% year-over-year to $320000.0; the TTM figure through Dec 2025 stood at $320000.0 (down 47.8% YoY), while the FY2025 annual figure was $320000.0, down 47.8% from the prior year.
- Other Accumulated Expenses was $320000.0 for Q4 2025 at Biofrontera, down from $681000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $683000.0 in Q2 2025 to a low of $320000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Biofrontera | 8.65 Mn | 2.24 Mn | 14.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 320,000.00 |
| Sep 30, 2025 | 681,000.00 |
| Jun 30, 2025 | 683,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 613,000.00 |